Results 11 to 20 of about 28,560 (247)

Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study

BMC Infectious Diseases, 2009
Background In patients with chronic respiratory disease, Pneumocystis jirovecii (P. jirovecii) colonization is observed, and may influence disease progression and systemic inflammation.
Shimizu Yasuo, Sunaga Noriaki, Dobashi Kunio, Fueki Makoto, Fueki Naoto, Makino Sohei, Mori Masatomo   +6 more
doaj   +2 more sources

Pneumocystis jirovecii colonization in chronic pulmonary disease

Parasite, 2011
Pneumocystis jirovecii causes pneumonia in immunosuppressed individuals. However, it has been reported the detection of low levels of Pneumocystis DNA in patients without signs and symptoms of pneumonia, which likely represents colonization.
Gutiérrez S., Respaldiza N., Campano E., Martínez-Risquez M.T., Calderón E.J., De La Horra C.   +5 more
doaj   +4 more sources

Axenic Long-Term Cultivation of Pneumocystis jirovecii

Journal of Fungi, 2023
Pneumocystis jirovecii, a fungus causing severe Pneumocystis pneumonia (PCP) in humans, has long been described as non-culturable. Only isolated short-term experiments with P.
Diana Riebold, Marie Mahnkopf, Kristina Wicht, Cristina Zubiria-Barrera, Jan Heise, Marcus Frank, Daniel Misch, Torsten Bauer, Hartmut Stocker, Hortense Slevogt   +9 more
doaj   +2 more sources

Successful long-term treatment of persistent pulmonary air leak in pneumocystis jirovecii pneumonia by unidirectional endobronchial valves [PDF]

Respiratory Medicine Case Reports, 2018
Spontaneous pneumothorax is a rare complication of pneumocystis jirovecii pneumonia. We report a patient with pneumocystis jirovecii pneumonia and therapy-refractory, right-sided pneumothorax due to persistent air leak (PAL) despite prolonged chest tube ...
Stefanie Bader, Christian Faul, Stephan Raab, Martin Schwaiblmair, Thomas M. Berghaus   +4 more
doaj   +2 more sources

Increasing Pneumocystis Pneumonia, England, UK, 2000–2010 [PDF]

Emerging Infectious Diseases, 2013
After an increase in the number of reported cases of Pneumocystis jirovecii pneumonia in England, we investigated data from 2000–2010 to verify the increase. We analyzed national databases for microbiological and clinical diagnoses of P.
Rishma Maini, Katherine L. Henderson, Elizabeth A. Sheridan, Theresa Lamagni, Gordon Nichols, Valerie Delpech, Nick Phin   +6 more
doaj   +2 more sources

Dihydropteroate synthase (DHPS) gene mutation study in HIV-Infected Indian patients with Pneumocystis jirovecii pneumonia

Journal of Infection in Developing Countries, 2010
Introduction: Pneumocystis jirovecii dihydropteroate synthase (DHPS) gene mutations' (55th and 57th codon) association with prior sulfa prophylaxis failure has been reported from both developed and developing countries.
Anuj Kumar Tyagi, Bijay Ranjan Mirdha, Kalpana Luthra, Randeep Guleria, Anant Mohan, Urvashi Balbir Singh, Jyotish Chandra Samantaray, Lalit Dar, Venkateswaran K Iyer, Rama Chaudhry   +9 more
doaj   +2 more sources

An overview of the laboratory diagnosis of Pneumocystis jirovecii pneumonia

Journal of Clinical Microbiology
ABSTRACT Pneumocystis jirovecii ( P. jirovecii ) is a fungal pathogen associated with significant morbidity in immunocompromised patients, including both HIV- and non-HIV-infected patients.
Alexis Jaramillo Cartagena, Osaretin Emmanuel Asowata, Dianna Ng, N. Esther Babady   +3 more
openaire   +3 more sources

pneumonia in a healthy immunocompetent patient: A case report and literature review

SAGE Open Medical Case Reports, 2023
Pneumocystis jirovecii pneumonia, typically an opportunistic infection, is commonly associated with risk factors such as low CD4+ lymphocyte count, underlying malignancies, organ transplantation, or immunosuppressive medications.
Houda Rouis, Chirine Moussa, Yoldez Houcine, Ines Zendah, Hamida Kwas, Habib Ghedira, Sonia Maâlej   +6 more
doaj   +2 more sources

Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations

Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 2015
Pneumocystis jirovecii infection causes fulminant interstitial pneumonia ( Pneumocystis pneumonia, PCP) in patients with rheumatoid arthritis (RA) who are receiving biological and/or nonbiological antirheumatic drugs.
Shunsuke Mori, Mineharu Sugimoto
doaj   +2 more sources

Late presentation of Pneumocystis jirovecii pneumonia after renal transplant: A case report

Medical Mycology Case Reports, 2018
The highest risk of opportunistic infections is from 1 to 6 months post-transplant. We report a rare case of Pneumocystis jirovecii pneumonia in a renal transplant recipient only on maintenance immunosuppression eleven years after transplant without ...
Prithiv Prasad, Kevin Bryan Lo, Pradhum Ram   +2 more
doaj   +2 more sources